← Leaderboards
Timothy J Lyons
Medical University Of South Carolina
$5,303,277
Attributed
$5,303,277
Total exposure
16
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–16$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$5,303,277 · 16
By mechanism
P20$3,007,020 · 2
R01$1,378,367 · 1
R21$534,831 · 1
P01$278,025 · 1
M01$105,034 · 11
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Maria F Lopes-Virella$3,980,090
- Ayad A Jaffa$7,063,873
- Julie Chao$9,369,252
- Yan Huang$5,705,032
- William Scott Argraves$10,691,634
Others in their field
Top investigators on “Oxidative Stress”
- Leonardo Trasande · New York University School Of Medicine$57,471,048
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$36,739,005
- Claire Gmachl · Princeton University$34,397,540
- Akram N Alshawabkeh · Northeastern University$31,872,089
- Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach)$31,629,832
- Robert O Wright · Brigham And Women'S Hospital$30,479,869
Research focus
Oxidative StressDiabetes MellitusPre-EclampsiaClinical ResearchApolipoproteinsDiabetic RetinopathyPreventHuman SubjectHypertensionCohortSamplingCross-Sectional StudiesDiabeticInflammationAntioxidantsWomanNon-DiabeticComplications Of Diabetes MellitusRisk FactorsNon-Insulin-Dependent Diabetes MellitusMinorityBlood VesselsPlasmaPregnancy
Grant awards (41)
EARLY MARKERS OF PRE-ECLAMPSIA IN NATIVE AMERICAN WITH TYPE 2 DIABETES$52,398
P20 · FY2016 · MD · contact PI
Pre-Eclampsia: Factors conferring Risk and Protectionn in Minority Women w/Dysgl$52,397
P20 · FY2016 · MD · contact PI
EARLY MARKERS OF PRE-ECLAMPSIA IN NATIVE AMERICAN WITH TYPE 2 DIABETES$52,833
P20 · FY2015 · MD · contact PI
Pre-Eclampsia: Factors conferring Risk and Protectionn in Minority Women w/Dysgl$52,831
P20 · FY2015 · MD · contact PI
EARLY MARKERS OF PRE-ECLAMPSIA IN NATIVE AMERICAN WITH TYPE 2 DIABETES$52,731
P20 · FY2014 · MD · contact PI
Pre-Eclampsia: Factors conferring Risk and Protectionn in Minority Women w/Dysgl$52,730
P20 · FY2014 · MD · contact PI
EARLY MARKERS OF PRE-ECLAMPSIA IN NATIVE AMERICAN WITH TYPE 2 DIABETES$49,493
P20 · FY2013 · MD · contact PI
Pre-Eclampsia: Factors conferring Risk and Protectionn in Minority Women w/Dysgl$49,486
P20 · FY2013 · MD · contact PI
Pre-Eclampsia: Factors conferring Risk and Protectionn in Minority Women w/Dysgl$176,685
P20 · FY2012 · MD · contact PI
EARLY MARKERS OF PRE-ECLAMPSIA IN NATIVE AMERICAN WITH TYPE 2 DIABETES$639,283
P20 · FY2011 · MD · contact PI
Lipoproteins and PEDF in the Vascular Complications of Diabetes$721,707
R01 · FY2010 · DK · contact PI
EARLY MARKERS OF PRE-ECLAMPSIA IN NATIVE AMERICAN WITH TYPE 2 DIABETES$529,186
P20 · FY2010 · MD · contact PI
Lipoproteins and PEDF in the Vascular Complications of Diabetes$656,660
R01 · FY2009 · DK · contact PI
EARLY MARKERS OF PRE-ECLAMPSIA IN NATIVE AMERICAN WITH TYPE 2 DIABETES$588,844
P20 · FY2009 · MD · contact PI
EARLY MARKERS OF PRE-ECLAMPSIA IN NATIVE AMERICAN WITH TYPE 2 DIABETES$369,763
P20 · FY2008 · MD · contact PI
EARLY MARKERS OF PRE-ECLAMPSIA IN NATIVE AMERICAN WITH TYPE 2 DIABETES$288,360
P20 · FY2007 · MD · contact PI
APOLIPOPROTEIN-BASED LIPOPROTEIN SUBCLASS PROFILES & VASC COMPLIC OF DIABETES$6,911
M01 · FY2007 · RR · contact PI
EFFECTS OF CHRONIC GREEN TEA FLAVONOID SUPPLEMENTATION ON BIOMARKERS OF OXIDATI$4,877
M01 · FY2007 · RR · contact PI
MARKERS AND MECHANISMS OF VASCULAR DISEASE IN DIABETES$405
M01 · FY2007 · RR · contact PI
MARKERS & MECHANISMS FOR PRE-ECLAMPSIA IN WOMEN W/TYPE 1 DIABETES$404
M01 · FY2007 · RR · contact PI
APOLIPOPROTEIN-BASED LIPOPROTEIN SUBCLASS PROFILES AMP; VASC COMPLIC OF DIABETES$42,979
M01 · FY2006 · RR · contact PI
MARKERS AMP; MECHANISMS FOR PRE-ECLAMPSIA IN WOMEN W/TYPE 1 DIABETES$3,234
M01 · FY2006 · RR · contact PI
Apolipoproteins and the complications of Type 1 diabetes$224,644
R21 · FY2005 · HL
LIPOPROTEINS AND OXIDATIVE STRESS$73,467
P01 · FY2005 · HL
APOLIPOPROTEIN-BASED LIPOPROTEIN SUBCLASS PROFILES &VASC COMPLIC OF DIABETES$9,965
M01 · FY2005 · RR
MARKERS &MECHANISMS FOR PRE-ECLAMPSIA IN WOMEN W/TYPE 1 DIABETES$6,185
M01 · FY2005 · RR
MARKERS AND MECHANISMS OF VASCULAR DISEASE IN DIABETES$1,374
M01 · FY2005 · RR
Apolipoproteins and the complications of Type 1 diabetes$310,187
R21 · FY2004 · HL
Markers &Mechanisms for Pre-Eclampsia in Women w/Type 1 Diabetes$11,259
M01 · FY2004 · RR
LIPOPROTEINS AND OXIDATIVE STRESS$73,467
P01 · FY2002 · HL
EPIDEMIOLOGY OF DIABETES INTERVENTION &COMPLICATIONS$0
M01 · FY2002 · RR
GLYCOXIDATION AND DIABETIC RETINOPATHY$0
M01 · FY2002 · RR
LIPOPROTEINS AND OXIDATIVE STRESS$73,467
P01 · FY2001 · HL
EPIDEMIOLOGY OF DIABETES INTERVENTION &COMPLICATIONS$0
M01 · FY2001 · RR
GLYCOXIDATION AND DIABETIC RETINOPATHY$0
M01 · FY2001 · RR
GLYCOXIDATION AND DIABETIC RETINOPATHY$0
M01 · FY2001 · RR
GLYCOXIDATION AND DIABETIC RETINOPATHY$0
M01 · FY2001 · RR
EPIDEMIOLOGY OF DIABETES INTERVENTION &COMPLICATIONS$0
M01 · FY2001 · RR
EPIDEMIOLOGY OF DIABETES INTERVENTION &COMPLICATIONS$0
M01 · FY2001 · RR
GLYCOXIDATION AND MACROVASCULAR DISEASE IN DIABETES$57,624
P01 · FY2000 · HL
GLYCOXIDATION AND DIABETIC RETINOPATHY$17,441
M01 · FY2000 · RR